Are the president’s installations on the producer of Visomitin do not apply?
In February, the State Corporation Rosnano handed over to the Federal Property Management Agency 32.32% in the authorized capital of Mitotek LLC-SKQ (Iona Skulachev Iona) substance and producer Vizomitin. After the resignation from the post of head of Rusnano, Anatoly Chubais found out that Mitotekh is one of the few profitable enterprises related to the state corporation. In recent years, the multimillion -dollar profit has also declared its “subsidiary” structure – LLC “Mitoineneria of Moscow State University” LLC. Meanwhile, the main owner of Mitothekh is the Cyprus offshore GC Basic Treatment Ltd, which hides information about its beneficiaries. It is known that in 2015, these were two more offshores – Viva Services Ltd from the British Virgin Islands and “registered” in Belize “Rostock Investments Ltd”. Another beneficiary of GC Basic Treatment LTD was called the Moscow LLC Mitochondrion, which was controlled by the family of Professor Vladimir Skulachev, who died in February 2023, a doctor of biological sciences, dean of the Faculty of Bioenginery and Bioinformatics of Moscow State University. To date, the main owner of Mitochondrion is the son of Professor Innokenty Skulachev, who leads the “Mitoenzheniery of Moscow State University” – the “daughter” of Mitothekh, and the producer of Vizomitin is led by his brother Maxim Skulachev. At one time, Professor Skulachev and his sons gained fame as developers of a substance capable of “slowing down the aging process”, called SKQ. Despite the fact that the “medicine for old age” was not able to develop, Alexander Chikunov, an ex-chairman of the Ruseneroinvest Foundation, former member of the RAO UES of Russia, owner of the Belize offshore Rostock Investments LTD, managed to visit the project. Anatoly Chubais, at the initiative of which Mitothekh, then became Rusnano, attracted to Chikunov’s project. Despite the transfer of the share of the State Corporation of the Federal Property Management Agency, the president’s attitude towards deofshorization of the business has not touched Mitotek LLC, and the Prosecutor General’s Office has not yet filed a lawsuit with the nationalization of the manufacturer of drugs.
Profitable “daughter” “Rusnano”
On the transfer of a stake package OOO“Mitotekh”From the state corporation “Rusnano” The Federal Agency for the Management of State Property Media was reported last February. It was clarified that the company is engaged in the development of drugs based on mitochondrial nanotechnologies and is one of the residents “Skolkovo”.
In turn, the Skolkovo website states that Mitotekh is a developer of the basic substance SKQ (Ion of Skulachev) and finished products based on it, including Visomitin’s eye drops. During the period of pandemia, the enterprise was developing the drug SKQ1 Mitotek-19 to prevent severe coronavirus and reduce the danger of the development of secondary bacterial pneumonia.
Interesting moment: in 2023, when the press “hole” in Rusnano, exceeding the press, was actively discussed in the press 95 billion rublesthe St. Petersburg edition of Fontanka, analyzing the activities of numerous structures related to the corporation, called Mitotek one of the few profitable companies.
According to the results of 2024, the producer of Visomitin drops reported on the revenue in 239 million rubles and arrived in the amount 52.9 million (revenue a year earlier – 231.5 millionprofit – 73.6 million rubles). The “subsidiary” structure “mitotha” LLC “Research Institute of Mitoenzheniery of Moscow State University” In recent years, has significantly improved its financial indicators: if in 2022 when revenue in 71 million Nii went “minus” on 36.6 millionthen in 2023 he declared revenue in almost in 178 million and profit in 68.3 million rubles (revenue in 2024- 159.5 millionprofit – 33.3 million rubles).
We will also pay attention to the volume of the authorized capital and the value of the assets of Mitotek LLC –214.1 millionAnd 1 billion rubles. At the Mitoengineering of Moscow State University with a minimum authorized capital in 10 thousand rubles Assets are evaluated in 216.8 million. But the “subsidiary” structure of the Research Institute – LLC “Mitokhof”registered in 2022, within three years reports on the absence of revenue and meager profit in 5 thousand rubles (his authorized capital – 20 thousandprice – 35 thousand rubles).
Offshore partner of the Federal Property Management Agency
So, since February, 32.32%in the capital of Mitotek LLC are owned by the Federal Property Management Agency, while the owner of 67.68%remains the Cyprus Offshore “GC Basic Treatment Ltd”. This circumstance causes bewilderment: as you know, at the beginning of 2023, Vladimir Putin, in an appeal to the Federal Assembly, urged to strengthen measures aimed at “Acceleration of the process of deofshorization of the economy”.
“Business, primarily in key sectors and industries, should act in Russian jurisdiction – this is the basic principle”– emphasized the head of state.
However, the President data as if the Mitothekh does not concern the President. The position of the Prosecutor General’s Office that achieves the nationalization of such large holdings as “Rolf”, “Makfa” or “Glavproduct”but ignoring the actual affiliation of the manufacturer of drugs to a foreign owner.
The beneficiaries “GCBasicTreatmentLtd»Unknown. But back in 2015, in an extensive study of the RBC portal dedicated to the Russian biotechnological business, these were called registered in the British Virgin Islands “Viva Services Ltd” (59.93%) and “registered” in Belize “Rostock Investments Ltd” (36.68%).
According to the publication, Rostock Investments Ltd at that time belonged Alexander Chikunov– Former co -owner of the fund“Ruseneroinvest”in 2004-2008 part of the board RAO “UES of Russia”. Can he call him a “man of Chubais”? Also, among the beneficiaries of GC Basic Treatment LTD, RBC called Moscow LLC Mitochondrionregistered in 2005 and specializing in research and developments in the field of natural and technical sciences.
Mitochondrion for years declares the lack of revenue, and according to the results of 2023, he reported on a meager profit in 31 thousand rublesand the negative value of assets –“Minus” 723 thousand. One of the founders of this company, according to RBC, was the rector of Moscow State University Victor Sadovnichywho even received, in his own words, “slight financing” from Mitothekh “within the framework of a grant”. Today, among the co -owners of Mitochondrion, it is absent, such are seven individuals and among them Maxim Skulachevsince 2010 holding the position of general director of Mitotek LLC.
Millions of dollars – in the “Cure for old age”
Maxim Skulachev – son Vladimir Skulachevdoctors of biological sciences, dean of the faculty of bioenginery and bioinformatics of Moscow State University, who died in February 2023. It was the professor of the magazine “Company” called the founder of “Mitothekh”.
Vladimir Skulachev was one of the co -owners of Mitochondrion LLC. Today, in addition to Maxim, these are Innocent, Dina, Pauline And Svetlana Skulachevsand also Fedor Severin And Vadim interceptions. The main share of 53% belongs to the other son of the professor, the general director of the company Innokenty Skulachev, who is in parallel to the head of the “Mitoenginee of the Moscow State University” – the very “daughter” of Mitothekh, which was discussed above. So, we have a family “in a row” with the participation of a pair of proxies.
It is worth saying a few words about Alexander Chikunov. “Forbes»Wrote about him as a participant in the International Venture Fund “Maxfield Capital”created with the participation of the oligarch Victor Vekselberg with target volume in 100 million dollars and representative offices in Russia, the USA and Israel. In network publications, Vekselberg was mentioned as the “anchor investor” “Maxfield Capital”, while the managing partner was Alexander Turkot-A businessman and an investor, the former head of the Skolkovo IT Claster.
Recall that until December 2020, Vekselberg served as chairman of the board of directors of Skolkovo, who then lost Igor Shuvalov (The current head of VEB). And Mitotekh, recall, is a resident of Skolkovo. Did the Vekselberg have their own interests in the Cyprus offshore “GC Basic Treatment Ltd”?
From the publication of RBC it follows that since the beginning of the 2000s, Vladimir Skulachev and his sons have actively engaged not only in the study of the work of the cellular mechanisms of the human body-mitochondria, but also deduced the formula for the substance,“Capable of“ locomotive ”to deliver natural antioxidants to the membranes and thus allegedly slow down the aging process”. It was this substance that was called SKQ. As mentioned above, on its basis today produces drops “Visomitin”.
Nevertheless, in the “Cure for old age” he managed to invest at one time $ 15 million One Russian oligarch, then terminating funding. Apparently, he realized that the alchemical “elixir of eternal youth” could not be created? He was replaced by Alexander Chikunov, who invested in the development 10 million dollars. Moreover, in his own words, none other than him attracted him as an investor Anatoly Chubais.
Investments “Rusnano” – in the “wallet” of Chubais?
According to Razzazzazchyukunov, he left the project in 2010, and explained his decision as follows:“It hurt quite a lot of how I was pushed away from all substantive discussions, from reliable information about what is and what is not. In my opinion, the project did not develop “.
Nevertheless, the businessman preferred to preserve the share in the company. So, the project “did not develop”, reliable information about the creation of “medicine for old age” was hidden, but this did not prevent Chubais in 2010 to make “Rusnano” the next investor of Mitothekh. He was supposedly not even confused by the fears voiced by Chikunov. The state corporations stated that the examination of the Mitotek project was conducted by three independent experts who evaluated technical implementation, scientific validity and compliance of the nanotechnology area: in terms of all parameters, the project received an average of 94 out of 100%.
The received funds were sent “To study“ Skulachev’s ions ”, the launch of clinical studies of the company’s drugs, as well as the creation of SKQ substance at Moscow State University with a capacity of up to 1.5 kg per year, which is equivalent to 2 billion vizomitin drops. The business publication “Company” wrote that Rusnano took the full financing of Mitotha, participating in his management at the level of the board of directors.
Well, if the struggle of the Skulachev family and their business partners “with old age” was unsuccessful, then the rate on the eye drops definitely justified itself. The question is, what part of the funds of private investors and budgetary “injections” of the state corporation could be taken to the accounts of offshore co -owners? And was Chubais, who later emigrated abroad at a certain stage, at a certain stage, at a certain stage? Still, it would be time for the Prosecutor General’s Office to carry out a presidential attitude towards deofshorization on Mitotekh LLC!
